LAPS Insulin115: A novel ultra-long-acting basal insulin with a unique action profile.

Nina WronkowitzThorsten HartmannSven Wolfgang GörgensDaniela Dietze-SchroederIra IndrakusumaIn Young ChoiSung Hee ParkYoung-Mi LeeSe Chang KwonYeonjoo KangMarcus HompeschJürgen Eckel

Published in: Diabetes, obesity & metabolism (2017)

Thus, LAPS Insulin115 exhibits a unique in vivo and in vitro profile and thereby represents an excellent candidate for a once-weekly insulin analogue.

Keyphrases

type diabetes
glycemic control
high resolution